Prothena Corp Public PRTA
NASDAQ PRTA
$8.78 +0.06 (+0.69%)
At close: Sep 29, 2026 · 4:00 PM EDT

Prothena Corp Public (PRTA) Cash from Restructuring (2018 - 2026)

Updated

Prothena Corp Public (PRTA) reported Cash from Restructuring of -$6.49 million for Q2 2026, compared with $30.33 million a year earlier.

Analysis

Prothena Corp Public (PRTA) Cash from Restructuring (2018 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Prothena Corp Public's Cash from Restructuring came in at -$23.04 million; for FY2025, it was $13.3 million.

  • Five-year quarterly Cash from Restructuring spans a low of -$12.72 million in Q3 2025 and a high of $30.33 million in Q2 2025.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $480,000 (Q1 2026), -$4.31 million (Q4 2025) and -$12.72 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Prothena Corp Public 451.21 Mn -804.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -6.49 Mn
Mar 31, 2026 480,000.00
Dec 31, 2025 -4.31 Mn
Sep 30, 2025 -12.72 Mn
Jun 30, 2025 30.33 Mn
Mar 31, 2019 -461,000.00
Dec 31, 2018 -3.88 Mn
Sep 30, 2018 -11.54 Mn
Jun 30, 2018 15.88 Mn
API Access

Prothena Corp Public Cash from Restructuring API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-restructuring&ticker=PRTA&period=max&api_key=YOUR_API_KEY